Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q1 2014

IBB Guru Trades in Q1 2014

Louis Moore Bacon 14,000 sh (-83.72%)
» More
Q3 2014

IBB Guru Trades in Q3 2014

George Soros 150,000 sh (unchged)
» More
Q4 2014

IBB Guru Trades in Q4 2014

John Keeley 905 sh (New)
» More
Q1 2015

IBB Guru Trades in Q1 2015

John Keeley 905 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with IBB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: »
Compare:0 » details
» More Articles for IBB

Headlines

Articles On GuruFocus.com
Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Targe Jul 23 2015 
Shen Jun 24 2015 
Shen Jun 24 2015 
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

More From Other Websites
Anacor Pharmaceuticals Outperforms the Market Jul 30 2015
Biogen’s Hemophilia Portfolio: Growing Market Share in 2Q15 Jul 30 2015
Large-Cap Healthcare Stocks Outperform Small Caps Jul 30 2015
Biogen’s Multiple Sclerosis Drugs Show 2Q15 Growth Jul 30 2015
This biotech stock is about to break out: Trader Jul 30 2015
These 4 Foreign Drug Stocks Have Broken Out Recently Jul 29 2015
Stocks Steady as Fed Heads Toward Rate Hike; Good Bye Growth Stocks? Jul 29 2015
Healthcare and Biotech Stocks Accelerate Their Longer-Term Trends Jul 29 2015
Mergers and Acquisitions Drive the Biotech Sector Jul 29 2015
Is Biotech a Bubble? Gilead Sciences Doesn't Think So Jul 29 2015
Biogen’s Weak 2Q15 Tecfidera Performance Dampens Sentiment Jul 29 2015
Gilead higher after earnings beat Jul 28 2015
Market Response to Biogen’s and Eli Lilly’s Alzheimer’s Drugs Jul 28 2015
Hep C revenue beats at Gilead Jul 28 2015
Biogen’s 2Q15 Earnings Beat Wall Street Estimates Jul 28 2015
Markets oversold, but these leaders still holding up Jul 28 2015
Eli Lilly’s Solanezumab: A Possible Cure for Alzheimer’s? Jul 28 2015
Next biotech deal brewing? Jul 27 2015
More pain for stocks? Jul 27 2015
Allergan to own 10% stake in Teva Jul 27 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK